We are live on ! Find out more
CRDF icon

Cardiff Oncology

87 hedge funds and large institutions have $132M invested in Cardiff Oncology in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 26 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more capital inflows, than outflows

Capital inflows: $13.7M | Capital outflows: $8.42M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.92% less ownership

Funds ownership: 53.41% → 52.48% (-0.92%)

4% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 26

7% less funds holding

Funds holding: 94 → 87 (-7)

33% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 21

34% less call options, than puts

Call options by funds: $895K | Put options by funds: $1.36M

Holders
87
Holders Change
-7
Holders Change %
-7.45%
% of All Funds
1.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
25
Reduced
26
Closed
21
Calls
$895​K
Puts
$1.36​M
Net Calls
-⁠$465​K
Net Calls Change
-⁠$766​K

CRDF Hedge Fund Activity: Q4 2021 in Review

87 of the 6,524 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q4 2021, worth a combined $132M — down 6.1% from $141M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of CRDF and 14 opened new positions — a net loss of 7 holders — while 26 trimmed existing stakes and 25 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $2.99M. The largest seller was Citadel Advisors, cutting an estimated $4.25M.

  • 87 institutional investors held Cardiff Oncology (CRDF) as of Q4 2021, down from 94 in Q3 2021.
  • Funds reported $132M of Cardiff Oncology stock for Q4 2021, down 6.1% quarter-over-quarter.
  • 14 funds opened new Cardiff Oncology positions in Q4 2021 and 21 closed out, a net change of -7 holders.
  • The largest Cardiff Oncology buyer in Q4 2021 was Point72 Asset Management, an estimated $2.99M added.
  • The largest Cardiff Oncology seller in Q4 2021 was Citadel Advisors, an estimated $4.25M sold.

Based on aggregated 13F filings for Q4 2021.